Vitamin B12 is essential for myelination, and its deficiency leads to neurological deficits such as loss of coordination, memory loss, and psychosis. In this cutting-edge work, Pluvinage et Al. described for the first time that autoantibodies (Abs) against the transcobalamin receptor (CD320), discovered by PhIP-seq, were associated in eight patients with neurological disorders (i.e progressive tremor, ataxia, encephalopathy and psychosis). Anti-CD320 Abs were associated with normal serum B12 levels, but almost undetectable in cerebrospinal fluid (CSF). Immunomodulatory treatment and high-dose systemic B12 supplementation were useful for these patients with anti CD320 Abs, supporting the autoimmune etiology of the disorder.